DTRA Archives - EverGlade Consulting

Assay Expansion for Chemical Diagnostic System

Leave a Comment / DTRA, EverGlade Insights / By Max Higgins, Consultant

Assay-Expansion-for-Chemical-Diagnostics-System-SOO_Final The Defense Threat Reduction Agency’s Medical Diagnostics Branch (RD-CBMD) is driving innovation with its 2026 solicitation to expand the ChemDx platform. ChemDx is a handheld diagnostic device for rapid detection of chemical threats, such as nerve agents or certain pesticides, in blood from a finger prick. This effort seeks proposals from organizations interested in […]

Assay Expansion for Chemical Diagnostic System Read More »

DTRA MCDC RAIIC Funding Opportunity

Leave a Comment / DTRA, EverGlade Insights / By Hanna Greenblott, Senior Consultant

Final-draft-SOO-RAIIC The Joint Science and Technology Office (JSTO) Defense Threat Reduction Agency (DTRA) has announced an upcoming funding opportunity for members of the Medical CBRN Defense Consortium (MCDC) to develop technologies that can accelerate the identification and immune profile of novel antigens in emerging infectious diseases (EID). JSTO intends to incorporate the final technology into

DTRA MCDC RAIIC Funding Opportunity Read More »

DTRA Issues Draft SOO for Continual Blood Sampling Technology

Leave a Comment / DTRA, EverGlade Insights / By Merissa Muratori, Senior Consultant

Final-Draft-SOO-IMMIR The Joint Science and Technology Office (JSTO) within the Defense Threat Reduction Agency (DTRA) has announced an upcoming funding opportunity for members of the Medical CBRN Defense Consortium (MCDC). The objective of the IMMIR solicitation is to develop innovative technologies for vaccine monitoring via a compact wearable device that can analyze minute blood samples.

DTRA Issues Draft SOO for Continual Blood Sampling Technology Read More »

DTRA Issues SOO for Broad-Spectrum Therapeutics

Leave a Comment / DTRA, EverGlade Insights / By Stephen Richardson, Managing Consultant

August-24-Broad-Spectrum-SOO The Defense Threat Reduction Agency (DTRA) has released a Statement of Objectives (SOO) to develop prototype Medical Countermeasures (MCMs) aimed at addressing therapeutic indications of Warfigher exposure to viral and bacterial biothreat agents. Key Information and Deadlines The Project Agreement Holder must state if their proposal is for the solution of the objecties of

DTRA Issues SOO for Broad-Spectrum Therapeutics Read More »

Female scientist in a hazmat suit researching WMD-related security challenges

DTRA BAA Weapons of Mass Destruction Amendment

Leave a Comment / DTRA, EverGlade Insights, Time Sensitive / By Eric Jia-Sobota, Founder

DTRA BAA Outlines New Opportunity to Identify and Counter Weapons of Mass Destruction (WMD) through the Strategic Trends Research Initiative The Defense Threat Reduction Agency (DTRA) has amended its Broad Agency Announcement (BAA) to offer new funding opportunities through the Strategic Trends Research Initiative (STRI) for identifying and countering Weapons of Mass Destruction (WMD), defined

DTRA BAA Weapons of Mass Destruction Amendment Read More »

Female scientist with vile and PPE for DTRA Funding Guide

A Guide to DTRA Funding

Leave a Comment / DTRA, Guides / By Eric Jia-Sobota, Founder

A Guide to DTRA Funding: Application Process, Financial and Technical Requirements The Defense Threat Reduction Agency (DTRA) is a U.S. Department of Defense (DoD) agency that focuses on countering weapons of mass destruction. DTRA offers numerous funding opportunities for research and development projects, but navigating the technical and financial requirements can be challenging. This guide

A Guide to DTRA Funding Read More »

DTRA